Tamoxifen for breast cancer risk reduction: impact of alternative approaches to quality-of-life adjustment on cost-effectiveness analysis.
about
Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis.How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?Placing a price on medical device innovation: the example of total knee arthroplasty.Cost-effectiveness of chemoprevention of breast cancer using tamoxifen in a postmenopausal US population.Preference weights for chemotherapy side effects from the perspective of women with breast cancer.Disparities in total knee replacement: Population losses in quality-adjusted life years due to differential offer, acceptance, and complication rates for Black Americans.Economic evaluation of using a genetic test to direct breast cancer chemoprevention in white women with a previous breast biopsy.
P2860
Q30431831-B61B55C2-47EA-4539-8341-E1726E51175EQ33767120-C1ADB68F-EE31-491D-BA45-6A5A918FD179Q34720777-BA6B37D4-CEAD-4333-9696-1B8C46E3FFD4Q44469560-ADFA9D81-4A81-4A9B-9FAE-74DABA7FFB08Q48151443-0DA0ABF6-0672-44FB-89CF-2EF0186246C4Q49833888-F9D53E47-F874-4ECC-B1B3-66B42FE52C4CQ50460101-ABB83275-D77C-43B7-8BFE-DFEB1C1CFF64
P2860
Tamoxifen for breast cancer risk reduction: impact of alternative approaches to quality-of-life adjustment on cost-effectiveness analysis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Tamoxifen for breast cancer ri ...... n cost-effectiveness analysis.
@en
Tamoxifen for breast cancer ri ...... n cost-effectiveness analysis.
@nl
type
label
Tamoxifen for breast cancer ri ...... n cost-effectiveness analysis.
@en
Tamoxifen for breast cancer ri ...... n cost-effectiveness analysis.
@nl
prefLabel
Tamoxifen for breast cancer ri ...... n cost-effectiveness analysis.
@en
Tamoxifen for breast cancer ri ...... n cost-effectiveness analysis.
@nl
P2093
P1433
P1476
Tamoxifen for breast cancer ri ...... on cost-effectiveness analysis
@en
P2093
Christina Slee
Joy Melnikow
L Jay Helms
Miriam Kuppermann
Theodore J McCarthy
P304
P356
10.1097/MLR.0B013E318179250F
P577
2008-09-01T00:00:00Z